Spelman, T., Kalincik, T., Jokubaitis, V., Zhang, A., Pellegrini, F., Wiendl, H., . . . Butzkueven, H. (2016). Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Neurol Clin Pract.
Citação norma ChicagoSpelman, Tim, et al. "Comparative Efficacy of First-line Natalizumab Vs IFN-β or Glatiramer Acetate in Relapsing MS." Neurol Clin Pract 2016.
MLA引文Spelman, Tim, et al. "Comparative Efficacy of First-line Natalizumab Vs IFN-β or Glatiramer Acetate in Relapsing MS." Neurol Clin Pract 2016.
警告：這些引文格式不一定是100％准確.